miR-107 functions as a tumor suppressor by reducing the expression of NOTCH2, CD133, nestin and Matrix Metallopeptidase 12 (MMP-12) in GSCs, impairing stem cell proliferation and invasion. The gene discussed is NOTCH2; the disease is neoplasm.